Connective Tissue Growth Factor (CTGF/CCN2) Is Negatively Regulated during Neuron-Glioblastoma Interaction

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Romão, Luciana F ^a   Mendes, Fabio A ^a   Feitosa, Natalia M ^a   Faria, Jane Cristina O ^a   Coelho Aguiar, Juliana M ^a   de Souza, Jorge Marcondes ^a   Neto, Vivaldo Moura ^a   Abreu, José Garcia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL INTERACTION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TUMOR MICROENVIRONMENT;

ANIMALS; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; RATS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84873150287     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055605     Document Type: Article

References (77)

1. Spohr TC, Dezonne RS, Rehen SK, Gomes FC, (2011) Astrocytes treated by lysophosphatidic acid induce axonal outgrowth of cortical progenitors through extracellular matrix protein and epidermal growth factor signaling pathway. J Neurochem 119: 113-123.
2. Stipursky J, Romao L, Tortelli V, Neto VM, Gomes FC, (2011) Neuron-glia signaling: Implications for astrocyte differentiation and synapse formation. Life Sci 89: 524-531.
3. Lim DA, Alvarez-Buylla A, (1999) Interaction between astrocytes and adult subventricular zone precursors stimulates neurogenesis. Proc Natl Acad Sci U S A 96: 7526-7531.
4. Song H, Stevens CF, Gage FH, (2002) Astroglia induce neurogenesis from adult neural stem cells. Nature 417: 39-44.
5. Gomes FC, Maia CG, de Menezes JR, Neto VM, (1999) Cerebellar astrocytes treated by thyroid hormone modulate neuronal proliferation. Glia 25: 247-255.
6. Hatten ME, (2002) New directions in neuronal migration. Science 297: 1660-1663.
7. Nadarajah B, Parnavelas JG, (2002) Modes of neuronal migration in the developing cerebral cortex. Nat Rev Neurosci 3: 423-432.
8. Garcia-Abreu J, Moura Neto V, Carvalho SL, Cavalcante LA, (1995) Regionally specific properties of midbrain glia: I. Interactions with midbrain neurons. J Neurosci Res 40: 471-477.
9. Garcia-Abreu J, Mendes FA, Onofre GR, De Freitas MS, Silva LC, et al. (2000) Contribution of heparan sulfate to the non-permissive role of the midline glia to the growth of midbrain neurites. Glia 29: 260-272.
10. Mendes FA, Onofre GR, Silva LC, Cavalcante LA, Garcia-Abreu J, (2003) Concentration-dependent actions of glial chondroitin sulfate on the neuritic growth of midbrain neurons. Brain Res Dev Brain Res 142: 111-119.
11. Tessier-Lavigne M, Goodman CS, (1996) The molecular biology of axon guidance. Science 274: 1123-1133.
12. Shu T, Richards LJ, (2001) Cortical axon guidance by the glial wedge during the development of the corpus callosum. J Neurosci 21: 2749-2758.
13. Pfrieger FW, Barres BA, (1997) Synaptic efficacy enhanced by glial cells in vitro. Science 277: 1684-1687.
14. Nagler K, Mauch DH, Pfrieger FW, (2001) Glia-derived signals induce synapse formation in neurones of the rat central nervous system. J Physiol 533: 665-679.
15. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA, (2001) Control of synapse number by glia. Science 291: 657-661.
16. Eroglu C, Barres BA, (2010) Regulation of synaptic connectivity by glia. Nature 468: 223-231.
17. Wang S, Barres BA, (2000) Up a notch: instructing gliogenesis. Neuron 27: 197-200.
18. Hatten ME, (1985) Neuronal regulation of astroglial morphology and proliferation in vitro. J Cell Biol 100: 384-396.
19. Hatten ME, (1987) Neuronal inhibition of astroglial cell proliferation is membrane mediated. J Cell Biol 104: 1353-1360.
20. de Sampaio e Spohr TC, Martinez R, da Silva EF, Neto VM, Gomes FC, (2002) Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factor-beta1. Eur J Neurosci 16: 2059-2069.
21. Sousa Vde O, Romao L, Neto VM, Gomes FC, (2004) Glial fibrillary acidic protein gene promoter is differently modulated by transforming growth factor-beta 1 in astrocytes from distinct brain regions. Eur J Neurosci 19: 1721-1730.
22. Stipursky J, Gomes FC, (2007) TGF-beta1/SMAD signaling induces astrocyte fate commitment in vitro: implications for radial glia development. Glia 55: 1023-1033.
23. Gomes FC, Garcia-Abreu J, Galou M, Paulin D, Moura Neto V, (1999) Neurons induce GFAP gene promoter of cultured astrocytes from transgenic mice. Glia 26: 97-108.
24. Takano T, Lin JH, Arcuino G, Gao Q, Yang J, et al. (2001) Glutamate release promotes growth of malignant gliomas. Nat Med 7: 1010-1015.
25. Kleihues P, Burguer PC, Collins VP, Newcomb EW, Ohgaki H, et al. (2000) Pathology and genetics of tumours of the nervous system: IARC Press.
26. Alves TR, Lima FR, Kahn SA, Lobo D, Dubois LG, et al. (2011) Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sci 89: 532-539.
27. Wakimoto N, Wolf I, Yin D, O'Kelly J, Akagi T, et al. (2008) Nonsteroidal anti-inflammatory drugs suppress glioma via 15-hydroxyprostaglandin dehydrogenase. Cancer Res 68: 6978-6986.
28. Mason WP, (2008) Emerging drugs for malignant glioma. Expert Opin Emerg Drugs 13: 81-94.
29. Higgins SC, Pilkington GJ, (2010) The in vitro effects of tricyclic drugs and dexamethasone on cellular respiration of malignant glioma. Anticancer Res 30: 391-397.
30. Soletti RC, Alves T, Vernal J, Terenzi H, Anderluh G, et al. (2010) Inhibition of MAPK/ERK, PKC and CaMKII signaling blocks cytolysin-induced human glioma cell death. Anticancer Res 30: 1209-1215.
31. Amado NG, Cerqueira DM, Menezes FS, da Silva JF, Neto VM, et al. (2009) Isoquercitrin isolated from Hyptis fasciculata reduces glioblastoma cell proliferation and changes beta-catenin cellular localization. Anticancer Drugs 20: 543-552.
32. Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG, (2011) Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer. Life Sci 89: 545-554.
33. Pindzola RR, Doller C, Silver J, (1993) Putative inhibitory extracellular matrix molecules at the dorsal root entry zone of the spinal cord during development and after root and sciatic nerve lesions. Dev Biol 156: 34-48.
34. Powell SK, Kleinman HK, (1997) Neuronal laminins and their cellular receptors. Int J Biochem Cell Biol 29: 401-414.
35. Ziu M, Schmidt NO, Cargioli TG, Aboody KS, Black PM, et al. (2006) Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J Neurooncol 79: 125-133.
36. Faria J, Romao L, Martins S, Alves T, Mendes FA, et al. (2006) Interactive properties of human glioblastoma cells with brain neurons in culture and neuronal modulation of glial laminin organization. Differentiation 74: 562-572.
37. Pan LH, Beppu T, Kurose A, Yamauchi K, Sugawara A, et al. (2002) Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res 24: 677-683.
38. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, et al. (2004) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10: 2072-2081.
39. Chu CY, Chang CC, Prakash E, Kuo ML, (2008) Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 15: 675-685.
40. Dhar A, Ray A, (2010) The CCN family proteins in carcinogenesis. Exp Oncol 32: 2-9.
41. Brigstock DR, (1999) The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 20: 189-206.
42. Bork P, (1993) The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett 327: 125-130.
43. Abreu JG, Ketpura NI, Reversade B, De Robertis EM, (2002) Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4: 599-604.
44. Kireeva ML, Latinkic BV, Kolesnikova TV, Chen CC, Yang GP, et al. (1997) Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 233: 63-77.
45. Surveyor GA, Brigstock DR, (1999) Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. Growth Factors 17: 115-124.
46. Kondo Y, Nakanishi T, Takigawa M, Ogawa N, (1999) Immunohistochemical localization of connective tissue growth factor in the rat central nervous system. Brain Res 834: 146-151.
47. Martinerie C, Viegas-Pequignot E, Nguyen VC, Perbal B, (1997) Chromosomal mapping and expression of the human cyr61 gene in tumour cells from the nervous system. Mol Pathol 50: 310-316.
48. Hertel M, Tretter Y, Alzheimer C, Werner S, (2000) Connective tissue growth factor: a novel player in tissue reorganization after brain injury? Eur J Neurosci 12: 376-380.
49. Kothapalli D, Frazier KS, Welply A, Segarini PR, Grotendorst GR, (1997) Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ 8: 61-68.
50. Grotendorst GR, Okochi H, Hayashi N, (1996) A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7: 469-480.
51. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, et al. (2001) CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276: 10594-10601.
52. Leask A, Holmes A, Black CM, Abraham DJ, (2003) Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278: 13008-13015.
53. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, et al. (2002) CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62: 1149-1159.
54. Roberts PJ, Der CJ, (2007) Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 26: 3291-3310.
55. Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, et al. (2001) CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 268: 6058-6065.
56. Crean JK, Finlay D, Murphy M, Moss C, Godson C, et al. (2002) The role of p42/44 MAPK and protein kinase B in connective tissue growth factor induced extracellular matrix protein production, cell migration, and actin cytoskeletal rearrangement in human mesangial cells. J Biol Chem 277: 44187-44194.
57. Crean JK, Furlong F, Mitchell D, McArdle E, Godson C, et al. (2006) Connective tissue growth factor/CCN2 stimulates actin disassembly through Akt/protein kinase B-mediated phosphorylation and cytoplasmic translocation of p27(Kip-1). FASEB J 20: 1712-1714.
58. Nagai N, Klimava A, Lee WH, Izumi-Nagai K, Handa JT, (2009) CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways. Invest Ophthalmol Vis Sci 50: 1903-1910.
59. Trentin AG, Rosenthal D, Maura Neto V, (1995) Thyroid hormone and conditioned medium effects on astroglial cells from hypothyroid and normal rat brain: factor secretion, cell differentiation, and proliferation. J Neurosci Res 41: 409-417.
60. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
61. Lin CS, Lin G, Wang Z, Maddah SA, Lue TF, (2002) Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease. Biochem Biophys Res Commun 295: 1014-1019.
62. Teymoortash A, Tiemann M, Schrader C, Hartmann O, Werner JA, (2003) Transforming growth factor beta in chronic obstructive sialadenitis of human submandibular gland. Arch Oral Biol 48: 111-116.
63. Lima FR, Trentin AG, Rosenthal D, Chagas C, Moura Neto V, (1997) Thyroid hormone induces protein secretion and morphological changes in astroglial cells with an increase in expression of glial fibrillary acidic protein. J Endocrinol 154: 167-175.
64. Grotendorst GR, (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179.
65. Garcia Abreu J, Coffinier C, Larrain J, Oelgeschlager M, De Robertis EM, (2002) Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systems. Gene 287: 39-47.
66. Ernst A, Campos B, Meier J, Devens F, Liesenberg F, et al. (2010) De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Oncogene 29: 3411-3422.
67. Yue J, Frey RS, Mulder KM, (1999) Cross-talk between Smad1 and Ras/MEK signaling pathways for TGFβ. Oncogene 18: 2033-2037.
68. Yang M, Huang H, Li J, Li D, Wang H, (2004) Tyrosine phosphorylation of the LDL receptor-related protein (LRP) and activation of the ERK pathway are required for connective tissue growth factor to potentiate myofibroblast differentiation. FASEB J 18: 1920-1921.
69. Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, et al. (2009) CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145: 207-216.
70. Kennedy L, Liu S, Shi-Wen X, Chen Y, Eastwood M, et al. (2007) CCN2 is necessary for the function of mouse embryonic fibroblasts. Exp Cell Res 313: 952-964.
71. Shimo T, Koyama E, Sugito H, Wu C, Shimo S, et al. (2005) Retinoid signaling regulates CTGF expression in hypertrophic chondrocytes with differential involvement of MAP kinases. J Bone Miner Res 20: 867-877.
72. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, et al. (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537-549.
73. Demuth T, Rennert JL, Hoelzinger DB, Reavie LB, Nakada M, et al. (2008) Glioma cells on the run- the migratory transcriptome of 10 human glioma cell lines. BMC Genomics 9: 54.
74. Yin D, Chen W, O'Kelly J, Lu D, Ham M, et al. (2010) Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 127: 2257-2267.
75. Edwards LA, Woolard K, Son MJ, Li A, Lee J, et al. (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103: 1162-1178.
76. de Groot J, Sontheimer H, (2011) Glutamate and the biology of gliomas. Glia 59: 1181-1189.
77. Sontheimer H, (2008) A role for glutamate in growth and invasion of primary brain tumors. J Neurochem 105: 287-295.